 | • レポートコード：QFJ1-5775 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、A型肝炎ウイルス細胞受容体2の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（IMM-1802、LY-3321367、MCLA-134、CA-170、CA-327、ENUM-005、その他）、用途別市場規模（結腸がん、骨髄異形成、非小細胞肺がん、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・A型肝炎ウイルス細胞受容体2の市場動向 ・企業の競争状況、市場シェア ・A型肝炎ウイルス細胞受容体2の種類別市場規模と予測2016-2027（IMM-1802、LY-3321367、MCLA-134、CA-170、CA-327、ENUM-005、その他） ・A型肝炎ウイルス細胞受容体2の用途別市場規模と予測2016-2027（結腸がん、骨髄異形成、非小細胞肺がん、その他） ・A型肝炎ウイルス細胞受容体2の北米市場規模2016-2027（アメリカ、カナダ） ・A型肝炎ウイルス細胞受容体2の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・A型肝炎ウイルス細胞受容体2のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・A型肝炎ウイルス細胞受容体2の中南米市場規模2016-2027（メキシコ、ブラジル） ・A型肝炎ウイルス細胞受容体2の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Aurigene Discovery Technologies Ltd、BeiGene Ltd、Eli Lilly and Co、Enumeral Biomedical Holdings Inc、Incyte Corp、Interprotein Corp、Jounce Therapeutics Inc、Merus NV、Novartis AG、Sorrento Therapeutics Inc、Sutro Biopharma Inc、Tesaro Inc、Trellis Bioscience Inc） ・結論 |
Market Analysis and Insights: Global Hepatitis A Virus Cellular Receptor 2 Market
The global Hepatitis A Virus Cellular Receptor 2 market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hepatitis A Virus Cellular Receptor 2 market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hepatitis A Virus Cellular Receptor 2 market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hepatitis A Virus Cellular Receptor 2 market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hepatitis A Virus Cellular Receptor 2 market.
Global Hepatitis A Virus Cellular Receptor 2 Scope and Market Size
Hepatitis A Virus Cellular Receptor 2 market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hepatitis A Virus Cellular Receptor 2 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
IMM-1802
LY-3321367
MCLA-134
CA-170
CA-327
ENUM-005
Others
Segment by Application
Colon Cancer
Myelodysplastic
Non-Small Cell Lung Cancer
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Aurigene Discovery Technologies Ltd
BeiGene Ltd
Eli Lilly and Co
Enumeral Biomedical Holdings Inc
Incyte Corp
Interprotein Corp
Jounce Therapeutics Inc
Merus NV
Novartis AG
Sorrento Therapeutics Inc
Sutro Biopharma Inc
Tesaro Inc
Trellis Bioscience Inc
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hepatitis A Virus Cellular Receptor 2 Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 IMM-1802
1.2.3 LY-3321367
1.2.4 MCLA-134
1.2.5 CA-170
1.2.6 CA-327
1.2.7 ENUM-005
1.2.8 Others
1.3 Market by Application
1.3.1 Global Hepatitis A Virus Cellular Receptor 2 Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Colon Cancer
1.3.3 Myelodysplastic
1.3.4 Non-Small Cell Lung Cancer
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hepatitis A Virus Cellular Receptor 2 Market Perspective (2016-2027)
2.2 Hepatitis A Virus Cellular Receptor 2 Growth Trends by Regions
2.2.1 Hepatitis A Virus Cellular Receptor 2 Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hepatitis A Virus Cellular Receptor 2 Historic Market Share by Regions (2016-2021)
2.2.3 Hepatitis A Virus Cellular Receptor 2 Forecasted Market Size by Regions (2022-2027)
2.3 Hepatitis A Virus Cellular Receptor 2 Industry Dynamic
2.3.1 Hepatitis A Virus Cellular Receptor 2 Market Trends
2.3.2 Hepatitis A Virus Cellular Receptor 2 Market Drivers
2.3.3 Hepatitis A Virus Cellular Receptor 2 Market Challenges
2.3.4 Hepatitis A Virus Cellular Receptor 2 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hepatitis A Virus Cellular Receptor 2 Players by Revenue
3.1.1 Global Top Hepatitis A Virus Cellular Receptor 2 Players by Revenue (2016-2021)
3.1.2 Global Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Players (2016-2021)
3.2 Global Hepatitis A Virus Cellular Receptor 2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hepatitis A Virus Cellular Receptor 2 Revenue
3.4 Global Hepatitis A Virus Cellular Receptor 2 Market Concentration Ratio
3.4.1 Global Hepatitis A Virus Cellular Receptor 2 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hepatitis A Virus Cellular Receptor 2 Revenue in 2020
3.5 Hepatitis A Virus Cellular Receptor 2 Key Players Head office and Area Served
3.6 Key Players Hepatitis A Virus Cellular Receptor 2 Product Solution and Service
3.7 Date of Enter into Hepatitis A Virus Cellular Receptor 2 Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hepatitis A Virus Cellular Receptor 2 Breakdown Data by Type
4.1 Global Hepatitis A Virus Cellular Receptor 2 Historic Market Size by Type (2016-2021)
4.2 Global Hepatitis A Virus Cellular Receptor 2 Forecasted Market Size by Type (2022-2027)
5 Hepatitis A Virus Cellular Receptor 2 Breakdown Data by Application
5.1 Global Hepatitis A Virus Cellular Receptor 2 Historic Market Size by Application (2016-2021)
5.2 Global Hepatitis A Virus Cellular Receptor 2 Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Hepatitis A Virus Cellular Receptor 2 Market Size (2016-2027)
6.2 North America Hepatitis A Virus Cellular Receptor 2 Market Size by Type
6.2.1 North America Hepatitis A Virus Cellular Receptor 2 Market Size by Type (2016-2021)
6.2.2 North America Hepatitis A Virus Cellular Receptor 2 Market Size by Type (2022-2027)
6.2.3 North America Hepatitis A Virus Cellular Receptor 2 Market Size by Type (2016-2027)
6.3 North America Hepatitis A Virus Cellular Receptor 2 Market Size by Application
6.3.1 North America Hepatitis A Virus Cellular Receptor 2 Market Size by Application (2016-2021)
6.3.2 North America Hepatitis A Virus Cellular Receptor 2 Market Size by Application (2022-2027)
6.3.3 North America Hepatitis A Virus Cellular Receptor 2 Market Size by Application (2016-2027)
6.4 North America Hepatitis A Virus Cellular Receptor 2 Market Size by Country
6.4.1 North America Hepatitis A Virus Cellular Receptor 2 Market Size by Country (2016-2021)
6.4.2 North America Hepatitis A Virus Cellular Receptor 2 Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Hepatitis A Virus Cellular Receptor 2 Market Size (2016-2027)
7.2 Europe Hepatitis A Virus Cellular Receptor 2 Market Size by Type
7.2.1 Europe Hepatitis A Virus Cellular Receptor 2 Market Size by Type (2016-2021)
7.2.2 Europe Hepatitis A Virus Cellular Receptor 2 Market Size by Type (2022-2027)
7.2.3 Europe Hepatitis A Virus Cellular Receptor 2 Market Size by Type (2016-2027)
7.3 Europe Hepatitis A Virus Cellular Receptor 2 Market Size by Application
7.3.1 Europe Hepatitis A Virus Cellular Receptor 2 Market Size by Application (2016-2021)
7.3.2 Europe Hepatitis A Virus Cellular Receptor 2 Market Size by Application (2022-2027)
7.3.3 Europe Hepatitis A Virus Cellular Receptor 2 Market Size by Application (2016-2027)
7.4 Europe Hepatitis A Virus Cellular Receptor 2 Market Size by Country
7.4.1 Europe Hepatitis A Virus Cellular Receptor 2 Market Size by Country (2016-2021)
7.4.2 Europe Hepatitis A Virus Cellular Receptor 2 Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size (2016-2027)
8.2 Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size by Type
8.2.1 Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size by Type (2016-2027)
8.3 Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size by Application
8.3.1 Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size by Application (2016-2027)
8.4 Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size by Region
8.4.1 Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Hepatitis A Virus Cellular Receptor 2 Market Size (2016-2027)
9.2 Latin America Hepatitis A Virus Cellular Receptor 2 Market Size by Type
9.2.1 Latin America Hepatitis A Virus Cellular Receptor 2 Market Size by Type (2016-2021)
9.2.2 Latin America Hepatitis A Virus Cellular Receptor 2 Market Size by Type (2022-2027)
9.2.3 Latin America Hepatitis A Virus Cellular Receptor 2 Market Size by Type (2016-2027)
9.3 Latin America Hepatitis A Virus Cellular Receptor 2 Market Size by Application
9.3.1 Latin America Hepatitis A Virus Cellular Receptor 2 Market Size by Application (2016-2021)
9.3.2 Latin America Hepatitis A Virus Cellular Receptor 2 Market Size by Application (2022-2027)
9.3.3 Latin America Hepatitis A Virus Cellular Receptor 2 Market Size by Application (2016-2027)
9.4 Latin America Hepatitis A Virus Cellular Receptor 2 Market Size by Country
9.4.1 Latin America Hepatitis A Virus Cellular Receptor 2 Market Size by Country (2016-2021)
9.4.2 Latin America Hepatitis A Virus Cellular Receptor 2 Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Market Size (2016-2027)
10.2 Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Market Size by Type
10.2.1 Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Market Size by Type (2016-2027)
10.3 Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Market Size by Application
10.3.1 Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Market Size by Application (2016-2027)
10.4 Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Market Size by Country
10.4.1 Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Aurigene Discovery Technologies Ltd
11.1.1 Aurigene Discovery Technologies Ltd Company Details
11.1.2 Aurigene Discovery Technologies Ltd Business Overview
11.1.3 Aurigene Discovery Technologies Ltd Hepatitis A Virus Cellular Receptor 2 Introduction
11.1.4 Aurigene Discovery Technologies Ltd Revenue in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021)
11.1.5 Aurigene Discovery Technologies Ltd Recent Development
11.2 BeiGene Ltd
11.2.1 BeiGene Ltd Company Details
11.2.2 BeiGene Ltd Business Overview
11.2.3 BeiGene Ltd Hepatitis A Virus Cellular Receptor 2 Introduction
11.2.4 BeiGene Ltd Revenue in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021)
11.2.5 BeiGene Ltd Recent Development
11.3 Eli Lilly and Co
11.3.1 Eli Lilly and Co Company Details
11.3.2 Eli Lilly and Co Business Overview
11.3.3 Eli Lilly and Co Hepatitis A Virus Cellular Receptor 2 Introduction
11.3.4 Eli Lilly and Co Revenue in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021)
11.3.5 Eli Lilly and Co Recent Development
11.4 Enumeral Biomedical Holdings Inc
11.4.1 Enumeral Biomedical Holdings Inc Company Details
11.4.2 Enumeral Biomedical Holdings Inc Business Overview
11.4.3 Enumeral Biomedical Holdings Inc Hepatitis A Virus Cellular Receptor 2 Introduction
11.4.4 Enumeral Biomedical Holdings Inc Revenue in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021)
11.4.5 Enumeral Biomedical Holdings Inc Recent Development
11.5 Incyte Corp
11.5.1 Incyte Corp Company Details
11.5.2 Incyte Corp Business Overview
11.5.3 Incyte Corp Hepatitis A Virus Cellular Receptor 2 Introduction
11.5.4 Incyte Corp Revenue in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021)
11.5.5 Incyte Corp Recent Development
11.6 Interprotein Corp
11.6.1 Interprotein Corp Company Details
11.6.2 Interprotein Corp Business Overview
11.6.3 Interprotein Corp Hepatitis A Virus Cellular Receptor 2 Introduction
11.6.4 Interprotein Corp Revenue in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021)
11.6.5 Interprotein Corp Recent Development
11.7 Jounce Therapeutics Inc
11.7.1 Jounce Therapeutics Inc Company Details
11.7.2 Jounce Therapeutics Inc Business Overview
11.7.3 Jounce Therapeutics Inc Hepatitis A Virus Cellular Receptor 2 Introduction
11.7.4 Jounce Therapeutics Inc Revenue in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021)
11.7.5 Jounce Therapeutics Inc Recent Development
11.8 Merus NV
11.8.1 Merus NV Company Details
11.8.2 Merus NV Business Overview
11.8.3 Merus NV Hepatitis A Virus Cellular Receptor 2 Introduction
11.8.4 Merus NV Revenue in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021)
11.8.5 Merus NV Recent Development
11.9 Novartis AG
11.9.1 Novartis AG Company Details
11.9.2 Novartis AG Business Overview
11.9.3 Novartis AG Hepatitis A Virus Cellular Receptor 2 Introduction
11.9.4 Novartis AG Revenue in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021)
11.9.5 Novartis AG Recent Development
11.10 Sorrento Therapeutics Inc
11.10.1 Sorrento Therapeutics Inc Company Details
11.10.2 Sorrento Therapeutics Inc Business Overview
11.10.3 Sorrento Therapeutics Inc Hepatitis A Virus Cellular Receptor 2 Introduction
11.10.4 Sorrento Therapeutics Inc Revenue in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021)
11.10.5 Sorrento Therapeutics Inc Recent Development
11.11 Sutro Biopharma Inc
11.11.1 Sutro Biopharma Inc Company Details
11.11.2 Sutro Biopharma Inc Business Overview
11.11.3 Sutro Biopharma Inc Hepatitis A Virus Cellular Receptor 2 Introduction
11.11.4 Sutro Biopharma Inc Revenue in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021)
11.11.5 Sutro Biopharma Inc Recent Development
11.12 Tesaro Inc
11.12.1 Tesaro Inc Company Details
11.12.2 Tesaro Inc Business Overview
11.12.3 Tesaro Inc Hepatitis A Virus Cellular Receptor 2 Introduction
11.12.4 Tesaro Inc Revenue in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021)
11.12.5 Tesaro Inc Recent Development
11.13 Trellis Bioscience Inc
11.13.1 Trellis Bioscience Inc Company Details
11.13.2 Trellis Bioscience Inc Business Overview
11.13.3 Trellis Bioscience Inc Hepatitis A Virus Cellular Receptor 2 Introduction
11.13.4 Trellis Bioscience Inc Revenue in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021)
11.13.5 Trellis Bioscience Inc Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Hepatitis A Virus Cellular Receptor 2 Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of IMM-1802
Table 3. Key Players of LY-3321367
Table 4. Key Players of MCLA-134
Table 5. Key Players of CA-170
Table 6. Key Players of CA-327
Table 7. Key Players of ENUM-005
Table 8. Key Players of Others
Table 9. Global Hepatitis A Virus Cellular Receptor 2 Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Hepatitis A Virus Cellular Receptor 2 Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Hepatitis A Virus Cellular Receptor 2 Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Hepatitis A Virus Cellular Receptor 2 Market Share by Regions (2016-2021)
Table 13. Global Hepatitis A Virus Cellular Receptor 2 Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Hepatitis A Virus Cellular Receptor 2 Market Share by Regions (2022-2027)
Table 15. Hepatitis A Virus Cellular Receptor 2 Market Trends
Table 16. Hepatitis A Virus Cellular Receptor 2 Market Drivers
Table 17. Hepatitis A Virus Cellular Receptor 2 Market Challenges
Table 18. Hepatitis A Virus Cellular Receptor 2 Market Restraints
Table 19. Global Hepatitis A Virus Cellular Receptor 2 Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Hepatitis A Virus Cellular Receptor 2 Market Share by Players (2016-2021)
Table 21. Global Top Hepatitis A Virus Cellular Receptor 2 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis A Virus Cellular Receptor 2 as of 2020)
Table 22. Ranking of Global Top Hepatitis A Virus Cellular Receptor 2 Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Hepatitis A Virus Cellular Receptor 2 Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Hepatitis A Virus Cellular Receptor 2 Product Solution and Service
Table 26. Date of Enter into Hepatitis A Virus Cellular Receptor 2 Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Hepatitis A Virus Cellular Receptor 2 Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Type (2016-2021)
Table 30. Global Hepatitis A Virus Cellular Receptor 2 Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Hepatitis A Virus Cellular Receptor 2 Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Application (2016-2021)
Table 34. Global Hepatitis A Virus Cellular Receptor 2 Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Hepatitis A Virus Cellular Receptor 2 Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Hepatitis A Virus Cellular Receptor 2 Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Hepatitis A Virus Cellular Receptor 2 Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Hepatitis A Virus Cellular Receptor 2 Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Hepatitis A Virus Cellular Receptor 2 Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Hepatitis A Virus Cellular Receptor 2 Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Hepatitis A Virus Cellular Receptor 2 Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Hepatitis A Virus Cellular Receptor 2 Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Hepatitis A Virus Cellular Receptor 2 Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Hepatitis A Virus Cellular Receptor 2 Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Hepatitis A Virus Cellular Receptor 2 Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Hepatitis A Virus Cellular Receptor 2 Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Hepatitis A Virus Cellular Receptor 2 Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Hepatitis A Virus Cellular Receptor 2 Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Hepatitis A Virus Cellular Receptor 2 Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Hepatitis A Virus Cellular Receptor 2 Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Hepatitis A Virus Cellular Receptor 2 Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Hepatitis A Virus Cellular Receptor 2 Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Market Size by Country (2022-2027) & (US$ Million)
Table 66. Aurigene Discovery Technologies Ltd Company Details
Table 67. Aurigene Discovery Technologies Ltd Business Overview
Table 68. Aurigene Discovery Technologies Ltd Hepatitis A Virus Cellular Receptor 2 Product
Table 69. Aurigene Discovery Technologies Ltd Revenue in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021) & (US$ Million)
Table 70. Aurigene Discovery Technologies Ltd Recent Development
Table 71. BeiGene Ltd Company Details
Table 72. BeiGene Ltd Business Overview
Table 73. BeiGene Ltd Hepatitis A Virus Cellular Receptor 2 Product
Table 74. BeiGene Ltd Revenue in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021) & (US$ Million)
Table 75. BeiGene Ltd Recent Development
Table 76. Eli Lilly and Co Company Details
Table 77. Eli Lilly and Co Business Overview
Table 78. Eli Lilly and Co Hepatitis A Virus Cellular Receptor 2 Product
Table 79. Eli Lilly and Co Revenue in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021) & (US$ Million)
Table 80. Eli Lilly and Co Recent Development
Table 81. Enumeral Biomedical Holdings Inc Company Details
Table 82. Enumeral Biomedical Holdings Inc Business Overview
Table 83. Enumeral Biomedical Holdings Inc Hepatitis A Virus Cellular Receptor 2 Product
Table 84. Enumeral Biomedical Holdings Inc Revenue in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021) & (US$ Million)
Table 85. Enumeral Biomedical Holdings Inc Recent Development
Table 86. Incyte Corp Company Details
Table 87. Incyte Corp Business Overview
Table 88. Incyte Corp Hepatitis A Virus Cellular Receptor 2 Product
Table 89. Incyte Corp Revenue in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021) & (US$ Million)
Table 90. Incyte Corp Recent Development
Table 91. Interprotein Corp Company Details
Table 92. Interprotein Corp Business Overview
Table 93. Interprotein Corp Hepatitis A Virus Cellular Receptor 2 Product
Table 94. Interprotein Corp Revenue in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021) & (US$ Million)
Table 95. Interprotein Corp Recent Development
Table 96. Jounce Therapeutics Inc Company Details
Table 97. Jounce Therapeutics Inc Business Overview
Table 98. Jounce Therapeutics Inc Hepatitis A Virus Cellular Receptor 2 Product
Table 99. Jounce Therapeutics Inc Revenue in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021) & (US$ Million)
Table 100. Jounce Therapeutics Inc Recent Development
Table 101. Merus NV Company Details
Table 102. Merus NV Business Overview
Table 103. Merus NV Revenue in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021) & (US$ Million)
Table 104. Merus NV Recent Development
Table 105. Novartis AG Company Details
Table 106. Novartis AG Business Overview
Table 107. Novartis AG Hepatitis A Virus Cellular Receptor 2 Product
Table 108. Novartis AG Revenue in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021) & (US$ Million)
Table 109. Novartis AG Recent Development
Table 110. Sorrento Therapeutics Inc Company Details
Table 111. Sorrento Therapeutics Inc Business Overview
Table 112. Sorrento Therapeutics Inc Hepatitis A Virus Cellular Receptor 2 Product
Table 113. Sorrento Therapeutics Inc Revenue in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021) & (US$ Million)
Table 114. Sorrento Therapeutics Inc Recent Development
Table 115. Sutro Biopharma Inc Company Details
Table 116. Sutro Biopharma Inc Business Overview
Table 117. Sutro Biopharma Inc Hepatitis A Virus Cellular Receptor 2 Product
Table 118. Sutro Biopharma Inc Revenue in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021) & (US$ Million)
Table 119. Sutro Biopharma Inc Recent Development
Table 120. Tesaro Inc Company Details
Table 121. Tesaro Inc Business Overview
Table 122. Tesaro Inc Hepatitis A Virus Cellular Receptor 2 Product
Table 123. Tesaro Inc Revenue in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021) & (US$ Million)
Table 124. Tesaro Inc Recent Development
Table 125. Trellis Bioscience Inc Company Details
Table 126. Trellis Bioscience Inc Business Overview
Table 127. Trellis Bioscience Inc Hepatitis A Virus Cellular Receptor 2 Product
Table 128. Trellis Bioscience Inc Revenue in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021) & (US$ Million)
Table 129. Trellis Bioscience Inc Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hepatitis A Virus Cellular Receptor 2 Market Share by Type: 2020 VS 2027
Figure 2. IMM-1802 Features
Figure 3. LY-3321367 Features
Figure 4. MCLA-134 Features
Figure 5. CA-170 Features
Figure 6. CA-327 Features
Figure 7. ENUM-005 Features
Figure 8. Others Features
Figure 9. Global Hepatitis A Virus Cellular Receptor 2 Market Share by Application: 2020 VS 2027
Figure 10. Colon Cancer Case Studies
Figure 11. Myelodysplastic Case Studies
Figure 12. Non-Small Cell Lung Cancer Case Studies
Figure 13. Others Case Studies
Figure 14. Hepatitis A Virus Cellular Receptor 2 Report Years Considered
Figure 15. Global Hepatitis A Virus Cellular Receptor 2 Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Hepatitis A Virus Cellular Receptor 2 Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Hepatitis A Virus Cellular Receptor 2 Market Share by Regions: 2020 VS 2027
Figure 18. Global Hepatitis A Virus Cellular Receptor 2 Market Share by Regions (2022-2027)
Figure 19. Global Hepatitis A Virus Cellular Receptor 2 Market Share by Players in 2020
Figure 20. Global Top Hepatitis A Virus Cellular Receptor 2 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis A Virus Cellular Receptor 2 as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Hepatitis A Virus Cellular Receptor 2 Revenue in 2020
Figure 22. Global Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Type (2016-2021)
Figure 23. Global Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Type (2022-2027)
Figure 24. North America Hepatitis A Virus Cellular Receptor 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Hepatitis A Virus Cellular Receptor 2 Market Share by Type (2016-2027)
Figure 26. North America Hepatitis A Virus Cellular Receptor 2 Market Share by Application (2016-2027)
Figure 27. North America Hepatitis A Virus Cellular Receptor 2 Market Share by Country (2016-2027)
Figure 28. United States Hepatitis A Virus Cellular Receptor 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Hepatitis A Virus Cellular Receptor 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Hepatitis A Virus Cellular Receptor 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Hepatitis A Virus Cellular Receptor 2 Market Share by Type (2016-2027)
Figure 32. Europe Hepatitis A Virus Cellular Receptor 2 Market Share by Application (2016-2027)
Figure 33. Europe Hepatitis A Virus Cellular Receptor 2 Market Share by Country (2016-2027)
Figure 34. Germany Hepatitis A Virus Cellular Receptor 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Hepatitis A Virus Cellular Receptor 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Hepatitis A Virus Cellular Receptor 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Hepatitis A Virus Cellular Receptor 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Hepatitis A Virus Cellular Receptor 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Hepatitis A Virus Cellular Receptor 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Share by Region (2016-2027)
Figure 44. China Hepatitis A Virus Cellular Receptor 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Hepatitis A Virus Cellular Receptor 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Hepatitis A Virus Cellular Receptor 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Hepatitis A Virus Cellular Receptor 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Hepatitis A Virus Cellular Receptor 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Hepatitis A Virus Cellular Receptor 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Hepatitis A Virus Cellular Receptor 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Hepatitis A Virus Cellular Receptor 2 Market Share by Type (2016-2027)
Figure 52. Latin America Hepatitis A Virus Cellular Receptor 2 Market Share by Application (2016-2027)
Figure 53. Latin America Hepatitis A Virus Cellular Receptor 2 Market Share by Country (2016-2027)
Figure 54. Mexico Hepatitis A Virus Cellular Receptor 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Hepatitis A Virus Cellular Receptor 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Market Share by Country (2016-2027)
Figure 60. Turkey Hepatitis A Virus Cellular Receptor 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Hepatitis A Virus Cellular Receptor 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Hepatitis A Virus Cellular Receptor 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Aurigene Discovery Technologies Ltd Revenue Growth Rate in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021)
Figure 64. BeiGene Ltd Revenue Growth Rate in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021)
Figure 65. Eli Lilly and Co Revenue Growth Rate in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021)
Figure 66. Enumeral Biomedical Holdings Inc Revenue Growth Rate in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021)
Figure 67. Incyte Corp Revenue Growth Rate in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021)
Figure 68. Interprotein Corp Revenue Growth Rate in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021)
Figure 69. Jounce Therapeutics Inc Revenue Growth Rate in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021)
Figure 70. Merus NV Revenue Growth Rate in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021)
Figure 71. Novartis AG Revenue Growth Rate in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021)
Figure 72. Sorrento Therapeutics Inc Revenue Growth Rate in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021)
Figure 73. Sutro Biopharma Inc Revenue Growth Rate in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021)
Figure 74. Tesaro Inc Revenue Growth Rate in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021)
Figure 75. Trellis Bioscience Inc Revenue Growth Rate in Hepatitis A Virus Cellular Receptor 2 Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
世界の非小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all lung cancers. The strong drug pipeline and drug approvals are one of the critical factors that will trigger the non-small cell lung cancer drug…- C型肝炎ウイルスエンベロープタンパク質E2のグローバル市場調査 2019年 The global Hepatitis C Virus Envelope Protein E2 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hepatitis C Virus Envelope Protein E2 volume and value at global level, regional level and company le…
- C型肝炎ウイルス（HCV）検査のグローバル市場調査 2019年 The global Hepatitis C Virus (HCV) Testing market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hepatitis C Virus (HCV) Testing volume and value at global level, regional level and company level. From a …
- 世界のトール様受容体8市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Toll Like Receptor 8 Market The global Toll Like Receptor 8 market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report m…
- 非小細胞肺がん薬のグローバル市場：規模・現状・予測2019-2025 Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all lung cancers.The strong drug pipeline and drug approvals are one of the critical factors that will trigger the non-small cell lung cancer drugs…